Arrowhead Pharmaceuticals · 11 hours ago
Summer Intern, People Services & Culture
Verona, Wisconsin, United States
Internship
Onsite
Intern
$21/hr - $21/hrArrowhead Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing innovative drugs for diseases with a genetic basis. The People Services & Culture Intern will support various initiatives aimed at enhancing employee experience and operational effectiveness while gaining practical experience in HR functions.
BiotechnologyHealth CareNanotechnologyPharmaceutical
No H1B
Responsibilities
Support a variety of People Services & Culture initiatives across the organization
Assist with creating, updating, and organizing documentation and templates
Collaborate with team members and stakeholders to gather information and support project needs
Help coordinate onboarding, engagement, and communication activities
Support employee-focused programs such as recognition and events
Maintain accurate records and assist with content organization and distribution
Contribute to special projects and administrative tasks as needed
Qualification
Required
Currently enrolled student at an accredited university or college
Demonstrated interest in Human Resources, Business Management, Organizational Development, or a related field
Excellent verbal and written communication skills
Strong organizational skills with attention to detail
Ability to manage multiple tasks and meet deadlines
Proficiency in Microsoft Office applications
Preferred
Interest in job architecture, talent management, or HR operations
Experience with documentation, templates, or content management
Strong interpersonal skills and comfort collaborating with stakeholders at various levels
Interest in employee engagement, onboarding, and culture-building initiatives
Self-starter mindset with a willingness to learn and take initiative
Benefits
Competitive salaries
Excellent benefit package
Company
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Founded in 1989
501-1000 employees
Funding
Current Stage
Public CompanyTotal Funding
$2.45BKey Investors
Sarepta TherapeuticsSixth StreetSilence Therapeutics
2026-01-07Post Ipo Equity· $200M
2026-01-07Post Ipo Debt· $625M
2024-11-26Post Ipo Equity· $325M
Leadership Team
Christopher Anzalone
President and Chief Executive Officer
Recent News
2026-01-08
Company data provided by crunchbase